CJ
Cecilia Jones
Chief Financial Officer

Cecilia Jones insider trades: Agios Pharmaceuticals (AGIO) stock sales

Chief Financial Officer, Agios Pharmaceuticals Last trade Apr 2, 2026 18 Form 4 filings
$334K
Sold, last 12 months
3 sales
$0
Bought, last 12 months
0 buys
11
Open-market trades
since 2023
2
Companies
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Cecilia reports to the SEC

Open-market buys and sales

11 trades reported on SEC Form 4, newest first

DateStockTypeValue
Apr 2, 2026AGIO↓ Sell$109K
Mar 2, 2026AGIO↓ Sell$146K
Dec 30, 2025AGIO↓ Sell$79K
Sep 26, 2025AGIO↓ Sell$134K
Jun 24, 2025AGIO↓ Sell$60K
Mar 3, 2025AGIO↓ Sell$81K
Sep 26, 2024AGIO↓ Sell$125K
Mar 5, 2024AGIO↓ Sell$22K
Jan 24, 2024AGIO↓ Sell$41K
Sep 28, 2023AGIO↓ Sell$54K
Jun 30, 2023AGIO↓ Sell$45K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other AGIO insiders

Open-market trades in the last 12 months

About Cecilia Jones's insider trades

Cecilia Jones is Chief Financial Officer at Agios Pharmaceuticals (AGIO). Since Jun 30, 2023, Cecilia has reported no open-market purchases and 11 sales worth $896K on SEC Form 4. In the last 12 months: 3 sales ($334K).

Their filings also include option exercises (13 filings), grants and awards (9 filings), shares withheld for taxes (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every AGIO insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.